The "Merkel cell carcinoma" is a rare tumor usually occuring in the sun-exposed skin. Its poor prognosis is explained by a high rate of metastasis (one third of the patients at the initial presentation) and a high post-operative recurrence rate. Descriptions of the imaging features of this type of tumor are rare. We present two cases of Merkel cell carcinoma localized to the head region. In the first patient, the lesion involved the soft tissues of the scalp with secondary invasion of the skull and meninges. The second patient had a metastasis to the parietal lobe.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0150-9861(05)83129-3 | DOI Listing |
Bull Cancer
March 2025
Dermatologie, CHU de Tours, Tours, France; Réseau CARADERM, France.
Merkel cell carcinoma (MCC) is a rare skin cancer that mainly affects the elderly, and whose incidence is increasing. Although the exact origin of this cancer remains uncertain, research in recent years has revealed that MCC develops through two oncogenesis pathways: virally induced by the Merkel polyomavirus (80% of cases) and induced by mutations linked to ultraviolet rays (20% of cases). MCC is an aggressive cancer, with a high mortality rate and limited therapeutic options in advanced stage.
View Article and Find Full Text PDFJ Am Acad Dermatol
March 2025
Fred Hutchinson Cancer Center, Seattle, WA; University of Washington, Seattle, WA. Electronic address:
Background: Merkel cell carcinoma (MCC) is an aggressive skin cancer with poor survival rates. Immune checkpoint inhibitors (ICIs) were FDA-approved for advanced MCC in 2017, but their real-world survival impact remains unclear.
Objective: Evaluate whether ICI introduction in the US corresponded with improved survival.
Redox Biol
March 2025
Department of Pathology, Medical University of Vienna, Vienna, Austria; European Research Initiative on ALK-Related Malignancies (ERIA), Cambridge, UK. Electronic address:
Anaplastic Large Cell Lymphoma (ALCL) is an aggressive T-cell lymphoma affecting children and young adults. About 30% of patients develop therapy resistance therefore new precision medicine drugs are highly warranted. Multiple rounds of structure-activity optimization of Caffeic Acid Phenethyl Ester have resulted in CM14.
View Article and Find Full Text PDFJ Neurol
March 2025
Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Background And Objectives: This study aimed to describe the clinical and prognostic characteristics of antibody-positive paraneoplastic neurological syndrome (PNS) associated with immune checkpoint inhibitors (ICIs).
Methods: We conducted a systematic review of relevant publications in PubMed and Embase from inception to December 2023. Patients with positive anti-neuronal antibodies who had a definite, probable, or possible diagnosis of PNS based on the 2021 PNS-Care Score criteria were included.
Br J Dermatol
February 2025
Department of Dermatology, Norfolk and Norwich University Hospital, Norfolk, UK.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!